{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:08:41Z","timestamp":1790615321932,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["10804"],"award-info":[{"award-number":["10804"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.pnpbp.2018.03.014","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T17:28:47Z","timestamp":1520875727000},"page":"267-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"PA","title":["Aripiprazole as an adjuvant treatment for obsessive and compulsive symptoms in manic phase of bipolar disorder: A randomized, double-blind, placebo-controlled clinical trial"],"prefix":"10.1016","volume":"84","author":[{"given":"Ali","family":"Sahraian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Ehsaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Mowla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2018.03.014_bb0005","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10578-016-0694-8","article-title":"Successful treatment response with aripiprazole augmentation of SSRIs in refractory obsessive-compulsive disorder in childhood","volume":"48","author":"Akyol Ardic","year":"2017","journal-title":"Child Psychiatry Hum. Dev."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0010","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.jpsychires.2013.08.005","article-title":"Clinical, psychological and environmental predictors of prospective suicide events in patients with bipolar disorder","volume":"47","author":"Antypa","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1192\/bjp.bp.114.150136","article-title":"Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials","volume":"208","author":"Barth","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0020","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.mp.4001823","article-title":"A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder","volume":"11","author":"Bloch","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/01677063.2017.1336236","article-title":"Obsessive-compulsive disorder, which genes? Which functions? Which pathways? An integrated holistic view regarding OCD and its complex genetic etiology","volume":"31","author":"Bozorgmehr","year":"2017","journal-title":"J. Neurogenet."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4088\/JCP.16m11201","article-title":"Efficacy and safety of aripiprazole once-monthly in the maintenance treatment of bipolar I disorder: a double-blind, placebo-controlled, 52-week randomized withdrawal study","volume":"78","author":"Calabrese","year":"2017","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","article-title":"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research","volume":"27","author":"Celada","year":"2013","journal-title":"CNS Drugs."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4088\/JCP.v66n0107","article-title":"The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients","volume":"66","author":"Connor","year":"2005","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/11208400-000000000-00000","article-title":"Aripiprazole: a review of its use in the management of schizophrenia in adults","volume":"26","author":"Croxtall","year":"2012","journal-title":"CNS Drugs."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0050","first-page":"130","article-title":"Co-morbidity of bipolar affective disorder and obsessive compulsive disorder in a Bedford community psychiatry team","volume":"23","author":"Darby","year":"2011","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cpr.2017.01.001","article-title":"Obsessions and compulsions in the lab: a meta-analysis of procedures to induce symptoms of obsessive-compulsive disorder","volume":"52","author":"De Putter","year":"2017","journal-title":"Clin. Psychol. Rev."},{"issue":"9","key":"10.1016\/j.pnpbp.2018.03.014_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv047","article-title":"Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: An update meta-analysis of double-blind, randomized, placebo-controlled trials","volume":"18","author":"Dold","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0065","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cpr.2004.08.004","article-title":"A multi-dimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder","volume":"24","author":"Eddy","year":"2004","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0070","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1399-5618.2008.00637.x","article-title":"Treatment-emergent mania\/hypomania during antidepressant mono-therapy in patients with rapid cycling bipolar disorder","volume":"10","author":"Gao","year":"2008","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0075","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1017\/S0033291711002637","article-title":"Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation andclinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive\u2013compulsive disorder","volume":"42","author":"Goes","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0080","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown obsessive compulsive scale: I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0085","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","article-title":"Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiological Survey on Alcohol and Related Conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/13651501.2016.1225098","article-title":"Aripiprazole augmentation in highly treatment-resistant obsessive\u2013compulsive disorder\u2013experience from a specialty clinic in India","volume":"21","author":"Hegde","year":"2017","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0095","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1017\/S0033291712000025","article-title":"Lifetime co-morbidity of DSM-IV disorders in the US national comorbidity survey replication adolescent supplement (NCS-A)","volume":"42","author":"Kessler","year":"2012","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.pnpbp.2018.03.014_bb0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1371\/journal.pone.0100069","article-title":"Active-state model of a dopamine D2 receptor-gai complex stabilized by aripiprazole-type partial agonists","volume":"9","author":"Kling","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-0327(95)00008-B","article-title":"Co-morbidity of obsessive\u2013compulsive disorder in bipolar disorder","volume":"34","author":"Kr\u00fcger","year":"1995","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/NDT.S122316","article-title":"Aripiprazole augmentation in managing comorbid obsessive-compulsive disorder and bipolar disorder: a case with suicidal attempts","volume":"28","author":"Lai","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pnpbp.2017.06.023","article-title":"Efficacy, safety and tolerability of aripiprazole in bipolar disorder: an updated systematic review and meta-analysis of randomized controlled trials","volume":"79","author":"Li","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0120","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/JCP.0b013e3181fab7b1","article-title":"Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder","volume":"30","author":"Masi","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0125","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0130","first-page":"177","article-title":"Tolerability and efficacy of aripiprazole long acting injection (lai) in bipolar disorder","volume":"18","author":"Moreno","year":"2016","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0135","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1517\/13543784.2014.971152","article-title":"Evaluating aripiprazole as a potential bipolar disorder therapy for adults","volume":"23","author":"Moro","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0140","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1017\/S1092852912000065","article-title":"Topiramate augmentation in resistant OCD: a double-blind placebo-controlled clinical trial","volume":"15","author":"Mowla","year":"2010","journal-title":"CNS Spectr."},{"issue":"1","key":"10.1016\/j.pnpbp.2018.03.014_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.pra.0000393848.35132.ff","article-title":"Clinical characteristics of patients with major depressive disorder with and without hypothyroidism: a comparative study","volume":"17","author":"Mowla","year":"2011","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/JCP.0b013e31820e3db6","article-title":"Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study","volume":"31","author":"Muscatello","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0155","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ebiom.2015.09.006","article-title":"A lifetime prevalence of comorbidity between bipolar affective disorder and anxiety disorders: a meta-analysis of 52 interview-based studies of psychiatric population","volume":"2","author":"Nabavi","year":"2015","journal-title":"EBioMedicine."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0165-0327(01)00433-5","article-title":"The temporal relationship between anxiety disorders and (hypo)mania: a retrospective examination of 63 panic, social phobic and obsessive-compulsive patients with co-morbid bipolar disorder","volume":"67","author":"Perugi","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/YIC.0b013e32832e9b91","article-title":"Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive\u2013compulsive disorder: a 12-week open-label preliminary study","volume":"24","author":"Pessina","year":"2009","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-0327(96)01405-X","article-title":"Prevalence of anxiety disorders co-morbidity in bipolar depression, unipolar depression and dysthymia","volume":"42","author":"Pini","year":"1997","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0175","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.psc.2014.05.006","article-title":"Pharmacological treatment of obsessive-compulsive disorder","volume":"37","author":"Pittenger","year":"2014","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0180","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jad.2014.05.015","article-title":"Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: a randomized double blind placebo controlled clinical trial","volume":"166","author":"Sahraian","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0185","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/JCP.0000000000000651","article-title":"Memantine as an adjuvant treatment for obsessive compulsive symptoms in manic phase of bipolar disorder: a randomized, double-blind, placebo-controlled clinical trial","volume":"37","author":"Sahraian","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0190","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0195","first-page":"1","article-title":"Serotonin 5-HT2B receptor antagonism is fundamental for protecting PC12 cells exposed to hydrogen peroxide","volume":"1","author":"Takayanagi","year":"2015","journal-title":"Fujita Med. J."},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0200","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.genhosppsych.2010.07.004","article-title":"Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder","volume":"32","author":"Uguz","year":"2010","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.03.014_bb0205","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12888-014-0317-5","article-title":"Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis","volume":"14","author":"Veale","year":"2014","journal-title":"BMC Psychiatr."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618300186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618300186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T09:34:00Z","timestamp":1535016840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584618300186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":41,"alternative-id":["S0278584618300186"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2018.03.014","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aripiprazole as an adjuvant treatment for obsessive and compulsive symptoms in manic phase of bipolar disorder: A randomized, double-blind, placebo-controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2018.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}